Multipurpose vaccine shows new promise in the presence of pre-existing immunity

Multipurpose vaccine shows new promise in the presence of pre-existing immunity

As researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer “immunologically naive”—in other words, our immune systems are familiar with certain variants of SARS-CoV-2. This familiarity can pose a problem for vaccine development.

​Medical Xpress – latest medical and health news stories

Read More


Discover more from Nurse Unity Chats

Subscribe to get the latest posts sent to your email.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *